NINA BRIDGES: Open Payments
NPI 1881131829 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 14 payments from 10 companies in 2025. Trend: 2023 $68 · 2024 $343 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Forte Bio-Pharma LLC | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Averitas Pharma Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $28 |
| Eisai Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: Belbuca, PROLATE, Ozempic, XIFAXAN, QUTENZA, Advantage System, Leqembi, INTELLIS ADAPTIVESTIM.
Industry payments across SC — which companies pay providers there.
